BMY   $60.59  5.21% Market Closed After Close 60.1422 -0.74%

Bristol-Myers Squibb Company

EMA (20): 2026-04-22 the price crossed down the moving average line and demonstrates a downside trend.

EMA (50): 2026-04-24 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

EMA (100): 2025-11-21 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -0.92%
EMA (20) date of signal April 22, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -0.77%
EMA (50) date of signal April 24, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 25.97%
EMA (100) date of signal Nov. 21, 2025, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal April 28, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -0.77%
MACD date of signal April 24, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -0.77%
Stochastic date of signal April 24, 2026, 3 a.m.
Updated April 29, 2026, 11 p.m.